Literature DB >> 26963567

Respective Roles of Hematopoietic and Nonhematopoietic Nod2 on the Gut Microbiota and Mucosal Homeostasis.

Ziad Alnabhani1, Jean-Pierre Hugot, Nicolas Montcuquet, Karine Le Roux, Monique Dussaillant, Maryline Roy, Marion Leclerc, Nadine Cerf-Bensussan, Patricia Lepage, Frédérick Barreau.   

Abstract

BACKGROUND: NOD2 mutations are associated with Crohn's disease (CD). Both CD (in human) and Nod2 deficiency (in mice) are characterized by increased mucosal CD4 T-cells, an altered permeability and a microbial dysbiosis. However, the respective roles of the gut epithelial and immune compartments on the phenotype are not known.
METHODS: Microbial composition, epithelial peptide secretion, intestinal permeability, and immune cell composition of Peyer patches were studied in Nod2 knock-out mice transplanted with wild-type bone marrow cells and vice versa.
RESULTS: The nonhematopoietic cells control the microbiota composition and epithelial secretion of mucins and antimicrobial peptides. These parameters are correlated with recurrent associations between bacterial species and luminal products. In contrast, Nod2 in the hematopoietic compartment regulates the epithelial permeability and the gut-associated lymphoid tissue independently of the bacterial composition.
CONCLUSIONS: The immune system and the gut permeability in one hand and the microbial and epithelial peptide compositions in the other hand are separate couples of interdependent parameters, both controlled by Nod2 in either the hematopoietic or nonhematopoietic lineages.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26963567     DOI: 10.1097/MIB.0000000000000749

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  10 in total

Review 1.  From sensing to shaping microbiota: insights into the role of NOD2 in intestinal homeostasis and progression of Crohn's disease.

Authors:  Iyshwarya Balasubramanian; Nan Gao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-27       Impact factor: 4.052

Review 2.  Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.

Authors:  Louis J Cohen; Judy H Cho; Dirk Gevers; Hiutung Chu
Journal:  Gastroenterology       Date:  2019-03-14       Impact factor: 22.682

Review 3.  Microbiota as a mediator of cancer progression and therapy.

Authors:  Jillian L Pope; Sarah Tomkovich; Ye Yang; Christian Jobin
Journal:  Transl Res       Date:  2016-08-03       Impact factor: 7.012

4.  NOD2 signaling in CD11c + cells is critical for humoral immune responses during oral vaccination and maintaining the gut microbiome.

Authors:  B E Fox; A Vilander; Z Abdo; G A Dean
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

5.  A specific gene-microbe interaction drives the development of Crohn's disease-like colitis in mice.

Authors:  R Caruso; T Mathes; E C Martens; N Kamada; A Nusrat; N Inohara; G Núñez
Journal:  Sci Immunol       Date:  2019-04-19

Review 6.  Nod2: The intestinal gate keeper.

Authors:  Ziad Al Nabhani; Gilles Dietrich; Jean-Pierre Hugot; Frederick Barreau
Journal:  PLoS Pathog       Date:  2017-03-02       Impact factor: 6.823

7.  Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction.

Authors:  Thomas Secher; Sahar Kassem; Mehdi Benamar; Isabelle Bernard; Michele Boury; Frederick Barreau; Eric Oswald; Abdelhadi Saoudi
Journal:  Front Immunol       Date:  2017-09-14       Impact factor: 7.561

Review 8.  Multi-Omics Analysis of Gut Microbiota in Inflammatory Bowel Diseases: What Benefits for Diagnostic, Prognostic and Therapeutic Tools?

Authors:  Vickie Lacroix; Alexis Cassard; Emmanuel Mas; Frederick Barreau
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

9.  Nod2 Deficiency in mice is Associated with Microbiota Variation Favouring the Expansion of mucosal CD4+ LAP+ Regulatory Cells.

Authors:  A Butera; M Di Paola; L Pavarini; F Strati; M Pindo; M Sanchez; D Cavalieri; M Boirivant; C De Filippo
Journal:  Sci Rep       Date:  2018-09-24       Impact factor: 4.379

Review 10.  NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis.

Authors:  Audrey Ferrand; Ziad Al Nabhani; Núria Solà Tapias; Emmanuel Mas; Jean-Pierre Hugot; Frédérick Barreau
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.